Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity has been approved for AMA PRA Category 1 Credits™.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669.
25th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma
Now in its 25th year, the annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma provides practitioners who manage hematologic malignancies with the practical tools to translate emerging data into the best therapy for their patients, to personalize care according to patient and tumor characteristics, and to apply novel treatment strategies to improve patient outcomes.
We are pleased to continue expanded coverage on chimeric antigen receptor (CAR) T cells and other immune-based therapies in 2021. First, a full afternoon session on Thursday, February 25, 2021, will be dedicated to addressing advances in CAR T-cell therapy for hematologic malignancies, as well as other immune-based therapies and strategies to overcome treatment resistance. Next, sessions on Friday, Saturday, and Sunday will focus on methods to apply state-of-the-art treatment strategies in your clinical practice setting. This engaging and highly interactive meeting will provide ample opportunity for attendees to interact with internationally renowned experts in the management of leukemias, lymphomas, myeloma, myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPNs), and benign hematologic malignancies. Our faculty will distill practice-changing evidence and recommend how to put this information into clinical context, so that you may apply the latest evidence to real-world patient-care scenarios. Proactive measures to mitigate and manage treatment-related toxicities associated with new cellular therapies will also be discussed. Finally, we will continue to provide expert opinion on how the value-based landscape will impact your clinical practice.
Interspersed throughout the meeting are sessions of Medical Crossfire®, a nationally recognized healthcare communication platform for debate, discussion, and peer exchange. These sessions will provide attendees with the opportunity to explore some of the most challenging clinical situations in the management of hematologic malignancies—treatment scenarios with multiple potential approaches.
This dynamic congress will inspire participants to reflect on and share the new information they have learned, and to apply these new practices in the clinical setting, with the ultimate goal of improving patient outcomes.
Physicians' Education Resource®’s top priority is ensuring the safety and security of our attendees, staff, and operational personnel. We are dedicated to remaining informed about the ongoing COVID-19 pandemic at the global and local levels. As we develop the programming for this activity, Physicians' Education Resource® will follow the guidelines to optimize health and conditions for attendees during the event. Ongoing updates on Physicians' Education Resource®'s plans related to this event, including education and programming, will continue to be available at www.gotoper.com/conferences/hem/meetings/25th-International-Congress-on-Hematologic-Malignancies-Focus-on-Leukemias-Lymphomas-and-Myeloma. Please note attendance at any public event increases the risk of contracting COVID-19 or other airborne illness, and attendees assume all risk associated with attendance. Any attendees who feel ill, regardless of their symptoms, should not attend this event.
Benefits of Attending
- Keep up-to-date with emerging and recently approved agents and approaches for patients with hematologic malignancies and benign hematologic disorders
- Learn about how molecular profiling and other emerging techniques for risk assessment can help optimize therapy for your patients
- Elevate your competence in managing treatment-related adverse events
- Network with your peers and internationally renowned experts in hematology/oncology
- How to apply newly approved agents in hematologic malignancies
- The latest developments in CAR T-cell therapy
- The increasing importance of genomics and molecular testing in hematologic malignancies
- How to cope with the emerging value-based care landscape
This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of hematologic malignancies may also participate.
Physician in Chief Hackensack Meridian Health Oncology Care Transformation Service
Chairman & Chief Physician Officer - John Theurer Cancer Center
Lydia Pfund Chair for Lymphoma
Academic Chairman Oncology- Hackensack Meridian School of Medicine at Seton Hall University
Professor of Medicine – Georgetown University
Director, Georgia Cancer Center
Eminent Scholar, Georgia Research Alliance
Professor and Chair, Department of Hematology & Medical Oncology
Emory School of Medicine
Chief Medical Officer
Winship Cancer Institute of Emory University
Registration fees include breakfast, breaks, receptions, and e-syllabus materials.
3 Ways to Register
- Online: Click here.
- Phone: Please call (888) 949-0045 or (609) 378-3701 (credit cards only).
- Fax: (609) 257-0705 (credit cards only).
Physicians' Education Resource - HEM21
|Nurses, PAs, Other Health Care Professionals||$199||$249|
*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount. Cannot be combined with other discounts/coupon codes.
**INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.
For registration assistance, please email email@example.com, or call +1-(888)-949-0045 or +1-(609)-378-3701.
A cancellation fee of 25% will be assessed on refunds requested prior to January 9, 2021, and a 50% fee on refunds requested from January 10, 2021, through February 7, 2021. No refunds will be made after February 8, 2021. There is no charge for substitution. Substitutions can only be applied to the same conference, and only 2 substitutions will be honored.
In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.
Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.
PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.
By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.
Meeting information is accurate at the time of posting.
PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.
You must be logged in to PER to register for this meeting
Or Register for PER now